↓ Skip to main content

MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia

Overview of attention for article published in Leukemia, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
31 Mendeley
Title
MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia
Published in
Leukemia, June 2015
DOI 10.1038/leu.2015.160
Pubmed ID
Authors

D C de Leeuw, H J M P Verhagen, F Denkers, F G Kavelaars, P J M Valk, G J Schuurhuis, G J Ossenkoppele, L Smit

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 6 19%
Student > Master 6 19%
Student > Ph. D. Student 4 13%
Other 3 10%
Student > Bachelor 2 6%
Other 6 19%
Unknown 4 13%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 32%
Medicine and Dentistry 5 16%
Agricultural and Biological Sciences 5 16%
Chemistry 2 6%
Environmental Science 1 3%
Other 4 13%
Unknown 4 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2016.
All research outputs
#3,319,525
of 24,003,070 outputs
Outputs from Leukemia
#926
of 5,213 outputs
Outputs of similar age
#41,815
of 267,308 outputs
Outputs of similar age from Leukemia
#12
of 77 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,213 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,308 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.